Ht-Logo-gigapixel-icon
Search
Close this search box.
Ht-Logo-gigapixel-icon
Search
Close this search box.
Monday, November 4, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Monday, November 4, 2024 | Latest Paper
Subscribe Now

TRENDING:

Philippe Gros and Mark Lathrop

Philippe Gros is deputy vice-principal, research and innovation, McGill University, and is an Officer of the Order of Canada. Mark Lathrop is a professor of Human Genetics, and director of the McGill and Genome Quebec Innovation Center at McGill University.

Personalized medicine is the future of health care

  • More than 90 per cent of new pharmaceutical compounds don’t make it out of clinical trials. The stratospheric failure rate, plus the need for
Opinion | BY PHILIPPE GROS AND MARK LATHROP | February 4, 2019
Personalized medicine tailors health care to an individual's genomic 'blueprint,' which along with lifestyle and environment, determines the risk of specific diseases and their outcomes, write Philippe Gros and Mark Lathrop. Photograph courtesy of Pixabay

Personalized medicine is the future of health care

Opinion | BY PHILIPPE GROS AND MARK LATHROP | February 4, 2019
  • More than 90 per cent of new pharmaceutical compounds don’t make it out of clinical trials. The stratospheric failure rate, plus the need for

Personalized medicine is the future of health care

Opinion | BY PHILIPPE GROS AND MARK LATHROP | February 4, 2019
  • More than 90 per cent of new pharmaceutical compounds don’t make it out of clinical trials. The stratospheric failure rate, plus the need for
Personalized medicine tailors health care to an individual's genomic 'blueprint,' which along with lifestyle and environment, determines the risk of specific diseases and their outcomes, write Philippe Gros and Mark Lathrop. Photograph courtesy of Pixabay

Personalized medicine is the future of health care

  • More than 90 per cent of new pharmaceutical compounds don’t make it out of clinical trials. The stratospheric failure rate, plus the need for
Opinion | BY PHILIPPE GROS AND MARK LATHROP | February 4, 2019
Personalized medicine tailors health care to an individual's genomic 'blueprint,' which along with lifestyle and environment, determines the risk of specific diseases and their outcomes, write Philippe Gros and Mark Lathrop. Photograph courtesy of Pixabay

Personalized medicine is the future of health care

Opinion | BY PHILIPPE GROS AND MARK LATHROP | February 4, 2019
  • More than 90 per cent of new pharmaceutical compounds don’t make it out of clinical trials. The stratospheric failure rate, plus the need for

Personalized medicine is the future of health care

Opinion | BY PHILIPPE GROS AND MARK LATHROP | February 4, 2019
  • More than 90 per cent of new pharmaceutical compounds don’t make it out of clinical trials. The stratospheric failure rate, plus the need for
Personalized medicine tailors health care to an individual's genomic 'blueprint,' which along with lifestyle and environment, determines the risk of specific diseases and their outcomes, write Philippe Gros and Mark Lathrop. Photograph courtesy of Pixabay
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

get help

Subscribe
CloseMenu